Inventor

STADHEIM TERRANCE A

US9 patents

⚠️ This page may combine multiple inventors who share the name “STADHEIM TERRANCE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

3 patents

US11959118B2Apr 16, 2024

Fc-containing polypeptides having improved properties and comprising mutations at positions 243 and 264 of the Fc-region

MERCK SHARP & DOHME0 citations55

US9758553B2Sep 12, 2017

Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose

MERCK SHARP & DOHME0 citations51

US10858686B2Dec 8, 2020

Method for preparing antibodies having improved properties

MERCK SHARP & DOHME0 citations50

BOBROWICZ PIOTR

2 patents

US9139632B2Sep 22, 2015

Method for producing proteins in Pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens

BOBROWICZ PIOTR5 citations69

US8936918B2Jan 20, 2015

Yeast strain for the production of proteins with modified O-glycosylation

BOBROWICZ PIOTR1 citations50

GLYCOFI INC

1 patent

US7259007B2Aug 21, 2007

Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins

GLYCOFI INC60 citations96

STADHEIM TERRANCE A

1 patent

US9187552B2Nov 17, 2015

Method for preparing antibodies having improved properties

STADHEIM TERRANCE A36 citations94

CELDARA MEDICAL LLC

1 patent

US11541076B2Jan 3, 2023

Chimeric antigen receptors targeting TIM-1

CELDARA MEDICAL LLC2 citations58

HAMILTON STEPHEN R

1 patent

US9528116B2Dec 27, 2016

Method for producing therapeutic proteins in Pichia pastoris lacking dipeptidyl aminopeptidase activity

HAMILTON STEPHEN R0 citations48